News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Danos Olivier
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/05/2023 |
4
| Danos Olivier (Chief Scientific Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Paid exercise price by delivering 2,058 shares
@ $22.68, valued at
$46.7k
Granted 65,930 shares
@ $0
Granted 52,986 options to buy
@ $22.25, valued at
$1.2M
|
|
| 01/04/2022 |
4
| Danos Olivier (Chief Scientific Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 555 shares
@ $33.0225, valued at
$18.3k
Granted 1 shares
@ $27.795, valued at
$27.8
Paid exercise price by delivering 1,221 shares
@ $32.7, valued at
$39.9k
Granted 10,700 shares
@ $0
Granted 51,100 options to buy
@ $34.31, valued at
$1.8M
|
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| Danos Olivier (Chief Scientific Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 48,000 options to buy
@ $38.99, valued at
$1.9M
|
|
| 04/17/2019 |
4
| Danos Olivier (Chief Scientific Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Sold 1,000 shares
@ $52.23, valued at
$52.2k
Sold 1,000 shares
@ $53.09, valued at
$53.1k
Exercised 2,000 options to buy
@ $20.35, valued at
$40.7k
|
|
| 03/14/2019 |
4
| Danos Olivier (Chief Scientific Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Exercised 5,000 options to buy
@ $20.35, valued at
$101.8k
|
|
| 01/07/2019 |
4
| Danos Olivier (Chief Scientific Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 48,000 options to buy
@ $40.82, valued at
$2M
|
|
| 12/04/2018 |
4
| Danos Olivier (Chief Scientific Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Exercised 1,500 options to buy
@ $20.35, valued at
$30.5k
|
|
| 10/10/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2018 |
4
| Danos Olivier (Chief Scientific Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 41,250 options to buy
@ $35.8, valued at
$1.5M
|
|
| 03/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/29/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|